Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Geron unveils ASH 2025 data linking RYTELO cytopenias, benefit | GERN Stock News

google.com·23w

Incyte stock price target raised to $128 by Leerink on mCALR data - Investing.com

google.com·23w

Karyopharm to Participate in Baird's Biotech Discovery Series - Dec 8, 2025

google.com·23w

Incyte rises after antibody therapy shows potential in rare blood cancers - TradingView

google.com·23w

Incyte&#39;s INCA033989: Promising <b>Myelofibrosis</b> Treatment Drives Buy Rating - TipRanks.com

google.com·23w

AI Screening Platform Accelerates Trial Recruitment in <b>Polycythemia Vera</b> - Consult QD

google.com·23w

Protagonist and Takeda report 52-week rusfertide data in <b>polycythemia vera</b> - StreetInsider

google.com·23w

Prelude Therapeutics presents early-stage cancer treatment data at ASH meeting

google.com·23w

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted ...

google.com·23w

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted ...

google.com·23w

Incyte Corporation (INCY) Discusses mutCALR Data and Therapeutic Advances in ... - Seeking Alpha

google.com·23w

Shining Light on How Protagonist, Takeda Drug Brings Treatment of a Rare Blood Disease ...

google.com·23w

Rusfertide Shows Promise in Treating <b>Polycythemia Vera</b> - Hematology Advisor

google.com·23w

INCA033989 With/Without Ruxolitinib Is Safe, Drives Spleen and Anemia Responses in ... - OncLive

google.com·23w

A promising sickle cell pill and a new way to treat <b>myelofibrosis</b> - STAT News

google.com·23w

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

google.com·23w

Incyte study results suggest a new approach to treating <b>myelofibrosis</b> - STAT News

google.com·23w

Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV - Medscape

google.com·23w

Incyte (INCY) Reveals Promising Phase 1 Results for INCA033989 i - GuruFocus

google.com·23w

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

google.com·23w

Log in to enable infinite scrolling